Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GNG11 |
| Upstream (Parents) |
|---|
| (<<) IL1R1 → GNG11 |
| (<<) ITPR3 → GNG11 |
| (<<) NNMT → GNG11 |
| (<<) NR3C1 → GNG11 |
| (<<) PTRF → GNG11 |
| Downstream (Children) |
|---|
| GNG11 → AXL (>>) |
| GNG11 → CAV1 (>>) |
| GNG11 → CDK6 (>>) |
| GNG11 → CLDN5 (>>) |
| GNG11 → CLEC2B (>>) |
| GNG11 → CXADR (>>) |
| GNG11 → CXCR7 (>>) |
| GNG11 → E2F1 (>>) |
| GNG11 → F2RL1 (>>) |
| GNG11 → GRB7 (>>) |
| GNG11 → GYPC (>>) |
| GNG11 → HKDC1 (>>) |
| GNG11 → HMOX1 (>>) |
| GNG11 → IFITM3 (>>) |
| GNG11 → KCTD12 (>>) |
| GNG11 → KLF2 (>>) |
| GNG11 → LAMB2 (>>) |
| GNG11 → LCP1 (>>) |
| GNG11 → MSN (>>) |
| GNG11 → MYLK (>>) |
| GNG11 → NUPR1 (>>) |
| GNG11 → PALM (>>) |
| GNG11 → PDE2A (>>) |
| GNG11 → RHOQ (>>) |
| GNG11 → ROCK2 (>>) |
| GNG11 → RPS6KA5 (>>) |
| GNG11 → SGK1 (>>) |
| GNG11 → SOX17 (>>) |
| GNG11 → SOX18 (>>) |
| GNG11 → SYNPO (>>) |
